TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 EUR)
Closing information | 2023/03 | 2022/03 | 2021/03 |
Turnover |
142,467
|
122,354
|
260,744 |
Earnings before taxes |
2,799
|
5,744
|
122,857 |
Total assets |
65,212
|
83,665
|
271,203 |
Current assets |
55,074
|
74,829
|
262,338 |
Current liabilities |
50,380
|
70,665
|
128,069 |
Equity capital |
12,739
|
10,922
|
140,696 |
- share capital |
1,356
|
1,358
![]() |
1,358 |
Employees (average) |
350
![]() |
350
![]() |
350 |
Financial ratios
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Solvency |
19.5%
|
13.1%
|
51.9% |
Turnover per employee |
407
|
350
|
745 |
Profit as a percentage of turnover |
2.0%
|
4.7%
|
47.1% |
Return on assets (ROA) | |||
Current ratio |
109.3%
|
105.9%
|
204.8% |
Return on equity (ROE) |
22.0%
|
52.6%
|
87.3% |
Change turnover |
20,292
|
-138,369
|
49,701 |
Change turnover % |
17%
|
-53%
|
24% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.